Vedanta pockets $12M from Johnson & Johnson on start of microbiome drug trial

Vedanta pockets $12M from Johnson & Johnson on start of microbiome drug trial

Source: 
Fierce Biotech
snippet: 

Vedanta Biosciences’ three-year-old collaboration with Johnson & Johnson on microbiome therapies has moved to the clinical stage, triggering a $12 million milestone payment.